News Chart Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE 04:00:00 2026-10-22 pm EDT			5-day change	1st Jan Change
2.260 ^USD	-1.74%		+0.89%	-17.82%

Oct. 08	Perspective Therapeutics, Inc. Receives Fast Track Designation for PSV359 for Treatment of Adult Patients with Locally Advanced Unresectable And/Or Metastatic FAP-Positive Solitary Fibrous Tumors	CI
Oct. 08	Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell	MT

3ad4f5d0c49.aiSEZbvOIavyUtn7I1Zk51-toICMMWX3XZXVhtNTik0.HmrrJIr-Y8W5IJ2SYCAIoxvj-LfLUByBJNaS9uFk2XgZbu0gzKVMmJg1lA~0173067d71c8fa0fdaf56adefd67c254